NeoGenomics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $181,330 | $168,035 | $172,000 | $167,824 |
Gross Profit | 77,258 | 73,246 | 77,257 | 74,880 |
EBITDA | -47,628 | -6,311 | 3,684 | 1,778 |
EBIT | -64,892 | -24,039 | -14,504 | -16,207 |
Net Income | -45,092 | -25,923 | -15,324 | -17,699 |
Net Change In Cash | 181,330 | 168,035 | 172,000 | 167,824 |
Free Cash Flow | 14,007 | -29,827 | -1,799 | -1,553 |
Cash | 154,723 | 346,194 | 367,012 | 361,992 |
Basic Shares | 25,589 | 25,475 | 25,331 | 25,390 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $660,566 | $591,643 | $509,728 | $484,329 |
Gross Profit | 290,100 | 244,604 | 187,896 | 187,060 |
EBITDA | -1,511 | -17,607 | -82,331 | -65,402 |
EBIT | -74,058 | -90,190 | -151,761 | -118,754 |
Net Income | -78,726 | -87,968 | -144,250 | -8,347 |
Net Change In Cash | 660,566 | 591,643 | 509,728 | 484,329 |
Cost of Revenue | -53,647 | 66,195 | ||
Free Cash Flow | -34,038 | -30,705 | -96,884 | -90,865 |
Cash | 367,012 | 342,488 | 263,180 | 316,827 |
Basic Shares | 25,331 | 25,100 | 24,843 | 23,992 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.03 |
2025-03-31 | -$0.20 |
2024-12-31 | $0.04 |
